# The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient

> **NCT02261545** · PHASE4 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 88 (estimated)

## Conditions studied

- Diabetes Mellitus Type II

## Interventions

- **DIETARY_SUPPLEMENT:** n-3 Fatty Acid
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02261545
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02261545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02261545, "The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02261545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*